These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33123281)

  • 21. DNA and RNA aptamers as modulators of protein function.
    Ulrich H
    Med Chem; 2005 Mar; 1(2):199-208. PubMed ID: 16787315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel insights into the role of aptamers in the fight against cancer.
    Maimaitiyiming Y; Hong F; Yang C; Naranmandura H
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):797-810. PubMed ID: 30830295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aptamers: potential applications to pancreatic cancer therapy.
    Rialon KL; White RR
    Anticancer Agents Med Chem; 2011 Jun; 11(5):434-41. PubMed ID: 21492073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.
    Shum KT; Zhou J; Rossi JJ
    J Cancer Ther; 2013 Jun; 4(4):872-890. PubMed ID: 25057429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of aptamers for targeted therapeutics.
    Ray P; Viles KD; Soule EE; Woodruff RS
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of Specific Aptamers.
    Liu S; Suzuki Y; Inui M
    Methods Mol Biol; 2024; 2766():129-137. PubMed ID: 38270872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancing Aptamers as Molecular Probes for Cancer Theranostic Applications-The Role of Molecular Dynamics Simulation.
    Jeevanandam J; Tan KX; Danquah MK; Guo H; Turgeson A
    Biotechnol J; 2020 Mar; 15(3):e1900368. PubMed ID: 31840436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The application of aptamers in cancer research: an up-to-date review.
    Hu M; Zhang K
    Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection and Application of Aptamers and Intramers.
    Avci-Adali M
    Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer immunotherapy via nucleic acid aptamers.
    Khedri M; Rafatpanah H; Abnous K; Ramezani P; Ramezani M
    Int Immunopharmacol; 2015 Dec; 29(2):926-936. PubMed ID: 26603636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamers: versatile probes for flow cytometry.
    Meyer M; Scheper T; Walter JG
    Appl Microbiol Biotechnol; 2013 Aug; 97(16):7097-109. PubMed ID: 23838792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligonucleotide aptamers for glioma targeting: an update.
    Camorani S; Cerchia L
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aptamers as imaging agents.
    Gomes Sda R; Azéma L; Allard M; Toulmé JJ
    Expert Opin Med Diagn; 2010 Nov; 4(6):511-8. PubMed ID: 23496229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aptamers: Biomedical Interest and Applications.
    Romero-López C; Berzal-Herranz A
    Pharmaceuticals (Basel); 2017 Mar; 10(1):. PubMed ID: 28300769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer.
    Shahdordizadeh M; Yazdian-Robati R; Ramezani M; Abnous K; Taghdisi SM
    J Mater Chem B; 2016 Dec; 4(48):7766-7778. PubMed ID: 32263769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.